|
Home | Technology News Search Engine:
|
|
|
|
Home: Technology News:
|
|
|
(IT-NEWSWIRE.COM, June 01, 2021 ) Transfection Reagent Market is expected to reach USD 1.02 Billion by 2021 from USD 715.4 Million in 2016, at a CAGR of 7.5% during the forecast period.
This growth can be attributed to factors such as advancements in transfection technology, global alliances among leading research institutes to trigger drug discovery, increase in R&D spending and research activities by pharmaceutical and biotechnology companies, increase in demand for synthetic genes, and rising incidence of cancer. Moreover, development of large scale transfections, rising demand of protein therapeutics, and emerging markets across India and China are likely to create opportunities for players operating in the market.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139141146
On the basis of method, the transfection reagent market is segmented into biochemical, physical, and viral. In 2016, the biochemical method segment is expected to command the largest share of the market. However, the viral method segment is projected to grow at the highest CAGR during the forecast period. The biochemical method segment is further divided into calcium phosphate, lipofection, DEAE-dextran, and dendrimer. In 2016, the lipofection segment is likely to account for the largest share of the transfection reagent market. Similarly, the physical method segment is classified into electroporation, nucleofection, and others (genegun, sonoporation, magnetofection, and optoinjection). In 2016, the electroporation segment is projected to account for the highest share of the market.
On the basis of end user, the transfection equipment market is segmented into academic & research institutes and pharmaceutical & biotechnologies companies. In 2016, the academic & research institutes is expected to account for the largest share of the market. However, the pharmaceutical & biotechnologies companies segment is projected to grow at the highest CAGR during the forecast period.
On the basis of application, the transfection reagent market is segmented into biomedical research, protein production, and therapeutic delivery. In 2016, the biomedical research segment is poised to account for the largest share of the transfection reagent market. However, the therapeutic delivery segment is expected to grow at the highest CAGR during the forecast period.
On the basis of region, the global transfection reagent market is segmented into North America, Europe, Asia-Pacific, and RoW. In 2016, North America is poised to account for the largest share of the market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period and serve as a major revenue pocket for companies offering transfection reagents and equipment.
Some of the major players in the global transfection reagent market include Thermo Fisher Scientific, Inc. (U.S.), Promega Corporation (U.S.), Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Polyplus-transfection SA (France), Bio-Rad Laboratories (U.S.), Lonza Group (Switzerland), Sigma-Aldrich Corporation (U.S.), Mirus Bio LLC (U.S.), and MaxCyte Inc.(U.S.).
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=139141146
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
MarketsandMarkets™
Mr. Aashish Mehra
1-888-600-6441
raviraj.tak@marketsandmarkets.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
|
Technology News Headlines
|
|
|
|
|
Technology Business Video Feed
|
|
More Technology Video Feeds
|
|
|
